Eurofins Discovery Announces Sponsorship of Bayer Co.Lab Cambridge in Support of Emerging Biotech Innovation
NEWS PROVIDED BY:
Eurofins Discovery
SAN DIEGO, CA – August 14, 2026 – Eurofins Discovery, a leading provider of products and services that support Pharma and Biotech to advance drug discovery and development, today announced a sponsorship agreement with Bayer Co.Lab Cambridge, Bayer’s premier life sciences incubator located in Kendall Square, Massachusetts. As a sponsor, Eurofins Discovery will gain visibility and engagement within one of the world’s most vibrant biotechnology innovation ecosystems, further strengthening its commitment to supporting the next generation of therapeutic innovators.
Through this sponsorship, Eurofins Discovery will have opportunities to engage with resident biotech companies, offering access to its comprehensive portfolio of drug discovery solutions, including chemistry, in vitro assay development, screening, and translational sciences. Through this access, Eurofins Discovery aims to help early-stage companies accelerate the progression of promising scientific discoveries.
Bayer Co.Lab Cambridge, part of Bayer’s global network of collaborative incubators, provides early-stage biotechnology companies with state-of-the-art laboratory facilities, scientific mentorship, and access to an extensive innovation network designed to foster breakthrough science. The Cambridge incubator supports pioneering research across multiple therapeutic areas, including oncology, immunology, neurology, cardiology, nephrology, and rare diseases.
As a sponsor of Bayer Co.Lab Cambridge, Eurofins Discovery reinforces its mission to be a trusted partner throughout the drug discovery journey, from early target ID and validation through preclinical candidate selection. The sponsorship reflects Eurofins Discovery’s ongoing investment in fostering scientific innovation and helping emerging companies overcome the challenges of bringing novel therapeutics to market.
Eurofins Discovery and Bayer Co.Lab Cambridge share a commitment to accelerating innovation, advancing biomedical research, and ultimately improving outcomes for patients through the development of next-generation medicines.
Media Contact
Director, Marketing Communications
aida.yodites@discovery.eurofinsus.com
About Eurofins Discovery
Eurofins Discovery supports drug discovery research with over 23,000 products and services developed in 40+ years of industry leadership. Benefit from the strength of our solutions that revolutionize your drug discovery.
About Bayer Co.Lab
Bayer Co.Lab is a global network of life science incubators focused on advancing disruptive innovation and scientific breakthroughs. With locations in leading innovation hubs worldwide, Bayer Co.Lab connects early-stage biotech entrepreneurs with state-of-the-art laboratory infrastructure, expert mentorship, and access to Bayer’s global expertise and networks. The program is designed to empower startups to transform pioneering ideas into impactful healthcare solutions for patients.
Questions? Contact Us
You can easily get in touch with a Eurofins Discovery Expert or get help from our Customer Service team. Reach out with questions, or to discuss your specific discovery challenges.
